STOCK TITAN
  1. Home
  2. Sec-filings
  3. AYTU
  4. [ARS] AYTU BIOPHARMA, INC SEC Filing

[ARS] AYTU BIOPHARMA, INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - AYTU BIOPHARMA, INC

ARS Filing - AYTU BIOPHARMA, INC

This filing is available as a PDF document.

Filing Type: ARS

Company: AYTU BIOPHARMA, INC (AYTU)

Acceptance Date: 2025-10-24T16:04:27.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock AYTU logo
Aytu Biopharma Inc

NASDAQ:AYTU

AYTU Rankings

#5938 Ranked by Market Cap
N/A Ranked by Dividends

AYTU Latest News

Jan 27, 2026
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
Jan 20, 2026
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
Jan 20, 2026
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
Jan 13, 2026
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
Jan 12, 2026
Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City

AYTU Latest SEC Filings

Jan 20, 2026
[8-K] AYTU BIOPHARMA, INC Reports Material Event
Nov 13, 2025
[10-Q] AYTU BIOPHARMA, INC Quarterly Earnings Report
Nov 13, 2025
[8-K] AYTU BIOPHARMA, INC Reports Material Event
Oct 24, 2025
[DEF 14A] AYTU BIOPHARMA, INC Definitive Proxy Statement
Oct 20, 2025
[Form 5] AYTU BIOPHARMA, INC Annual Statement of Beneficial Ownership

AYTU Stock Data

26.29M
9.64M
7.58%
38.09%
5.17%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
DENVER